期刊文献+

自拟益气养阴通络方联合厄贝沙坦治疗早期糖尿病肾病128例临床观察 被引量:5

Clinical observation on treating 128 cases of early diabetic nephropathy with the Yiqi Yangsheng Tongluo decoction plus Irbesartan
下载PDF
导出
摘要 目的:探讨自拟益气养阴通络方联合厄贝沙坦治疗早期糖尿病肾病的临床效果。方法:选择我科收治的128例早期糖尿病肾病患者,随机分为两组,其中观察组予以自拟益气养阴通络方联合厄贝沙坦治疗,对照组单纯予以厄贝沙坦治疗,每组各64例,治疗后观察两组患者疗效及比较肾功能指标。结果:与对照组有效率50.00%比较,观察组患者有效率68.75%升高明显,差异具有统计学意义(P<0.05)。治疗前,两组患者的24h、SCr、BUN比较,差异均无统计学意义(P>0.05);治疗后,观察组的各项指标虽均低于对照组,但差异均无统计学意义(P>0.05)。同组比较,治疗后,两组各项指标均较治疗前降低,差异具有统计学意义(P<0.05)。结论:自拟益气养阴通络方联合厄贝沙坦可有效提高治疗早期糖尿病肾病的疗效,但对于肾功能改善不明显。 Objective: To discuss clinical effect of Yiqi Yangyin Tongluo decoction combined with irbesartan on diabetic nephropathy. Methods: 128 early diabetic nephropathy patients who were treated in our department were selected and divided into 2 groups, observed group were given Yiqi Yangyin Tongluo decoction plus irbesartan, control group were simply given irbesartan, 64 cases in each group. Results: For clinical efficiency, control group was 50.00%, observed group was 68.75%, the difference come with statistical significance (P〈0.05). Compared within group, after treatment, both group's index lower than control group, with statistical significances (P〈O.05). Conclusion: Self-designed Yiqi Yangyin Tongluo decoction plus irbesartan can effectively improve early diabetic nephropathy, but can't obviously improve renal function.
机构地区 衡东县中医医院
出处 《中医临床研究》 2015年第10期82-83,共2页 Clinical Journal Of Chinese Medicine
关键词 糖尿病肾病 早期 益气养阴通络方 厄贝沙坦 疗效 肾功能 Diabetic nephropathy Early Yiqi Yangyin Tongluo decoction Irbesartan Curative effect Renal function
  • 相关文献

参考文献5

二级参考文献37

  • 1林兰.中西医结合糖尿病诊疗标准(草案)[J].中国中西医结合杂志,2005,25(1):94-95. 被引量:249
  • 2雷作熹,罗仁,董晓蕾,钟先阳.STZ诱导糖尿病肾病大鼠模型的建立[J].中国实验动物学报,2005,13(3):163-165. 被引量:83
  • 3张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:369
  • 4Strute F, Zeisberg M, Renziehausen A, et al. TGF-β1 induces proliferation in human renal fibroblast via induction of basic fibroblast growth factor (EGF-2) [J]. Kidney Int, 2001, 59(2): 579-592.
  • 5Schiller M, Bitzer M, Roberts Ian S D, et al. Apptosis in podocytes induced by TGF-β and smad7 [J]. J Clin Invest, 2001, 108: 807-816.
  • 6Liu Y H. Epithelial to mesenchymal transition in renal fibrosis: pathologic significance molecular mechanism and thera peuticintervention [J]. JAm SocNephrol, 2004, 15:1 -12.
  • 7Derynck R, Zhang Y E. Smad-dependent and Smad-independent path-ways in TGF-beta family signaling [J]. Nature, 2003, 425(6958): 577-584.
  • 8周仲英.中医内科学[M].北京:中国中医药出版社,2007:267-268.
  • 9G Soldatos, M E Cooper. Diabetic nephropathy: Important pathophysiologic mechanisms [ J ]. Diabetes Res Clin Pract, 2008 (82s) :75.
  • 10Seiya Sato, Harukiyo Kawamura, Minoru Takemoto, et al.Halofuginone prevents extracellular matrix deposition in diabetic nephropathy[ J]. Biochem Biophys Res Commun, 2009, 379: 411.

共引文献134

同被引文献35

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部